Development of dual responsive nanocomposite for simultaneous delivery of anticancer drugs

Journal of Drug Targeting

Volumn 22, Issue 4, 2014, Pages 327-342

  Salehi, Roya ^a,b   Hamishehkar, Hamed ^a   Eskandani, Morteza ^c   Mahkam, Mehrdad ^d   Davaran, Soodabeh ^e,f  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d AZARBAIJAN SHAHID MADANI UNIVERSITY   (Iran)

^e TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cancer; Dual drug delivery; Nanoparticles; Stimuli responsive; Targeted delivery

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; DOXORUBICIN; MESOPOROUS SILICA NANOPARTICLE; METHOTREXATE; NANOCARRIER; NANOCOMPOSITE; NANOPARTICLE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; DRUG CARRIER; SILICON DIOXIDE;

ARTICLE; CANCER CELL CULTURE; CELL ASSAY; CONTROLLED STUDY; CYTOTOXICITY ASSAY; DRUG DELIVERY SYSTEM; DRUG RELEASE; HUMAN; HUMAN CELL; HYDROGEN BOND; INCUBATION TIME; INFRARED SPECTROSCOPY; MTT ASSAY; PH; POLYMERIZATION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SCANNING ELECTRON MICROSCOPY; SYNTHESIS; TEMPERATURE; THERMOGRAVIMETRY; ZETA POTENTIAL; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARTICLE SIZE; SURFACE PROPERTY; TUMOR CELL LINE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL LINE, TUMOR; CELL SURVIVAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOXORUBICIN; DRUG CARRIERS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; METHOTREXATE; MICROSCOPY, ELECTRON, SCANNING; NANOCOMPOSITES; PARTICLE SIZE; SILICON DIOXIDE; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SURFACE PROPERTIES; THERMOGRAVIMETRY;

EID: 84898402598     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/1061186X.2013.876645     Document Type: Article

References (52)

1. Méndez J, Monteagudo A, Griebenow K. Stimulus-responsive controlled release system by covalent immobilization of an enzyme into mesoporous silica nanoparticles. Bioconjug Chem 2012;23: 698-704.
2. Xi J, Qin J, Fan L. Chondroitin sulfate functionalized mesos-tructured silica nanoparticles as biocompatible carriers for drug delivery. Int J Nanomedicine 2012;7:5235-47.
3. Tung WL, Hu SH, Liu DM. Synthesis of nanocarriers with remote magnetic drug release control and enhanced drug delivery for intracellular targeting of cancer cells. Acta Biomater 2011;7: 2873-82.
4. Yu MK, Park J, Jon S. Targeting strategies for multifunctional nanoparticles in cancer imaging and therapy. Theranostics 2012;2:3-44.
5. Ukmar T, Planinsek O. Ordered mesoporous silicates as matrices for controlled release of drugs. Acta Pharm 2010;60:373-85.
6. Gao Y, Chen Y, Ji X, et al. Controlled intracellular release of doxorubicin in multidrug-resistant cancer cells by tuning the shell-pore sizes of mesoporous silica nanoparticles. ACS nano 2011;5: 9788-98.
7. Zheng H, Huang Z, Che S. Mesostructured chitosan-silica hybrid as a biodegradable carrier for a pH-responsive drug delivery system. Dalton Transactions 2012;41:5038-44.
8. Deng Z, Zhen Z, Hu X, et al. Hollow chitosan-silica nanospheres as pH-sensitive targeted delivery carriers in breast cancer therapy. Biomaterials 2011;32:4976-86.
9. Hasanzadeh M, Shadjou N, Eskandani M, de la Guardia M. Mesoporous materials for use in electrochemical enzyme nanobio-sensors. TrAC Trends Analyt Chem 2012;45:93-106.
10. Yang P, Gai S, Lin J. Functionalized mesoporous silica materials for controlled drug delivery. Chem Soc Rev 2012; 41:3679-98.
11. Xing L, Zheng H, Cao Y, Che S. Coordination polymer coated mesoporous silica nanoparticles for pH-responsive drug release. Adv Mater 2012;24:6433-7.
12. Tang H, Guo J, Sun Y, et al. Facile synthesis of pH sensitive polymer-coated mesoporous silica nanoparticles and their application in drug delivery. Int J Pharm 2011;421:388-96.
13. Lee CH, Cheng SH, Huang I, et al. Intracellular pH-responsive mesoporous silica nanoparticles for the controlled release of anticancer chemotherapeutics. Angewandte Chemie 2010;122: 8390-5.
14. Zhao Y, Trewyn BG, Slowing II, Lin VS-Y. Mesoporous silica nanoparticle-based double drug delivery system for glucose-responsive controlled release of insulin and cyclic AMP. JACS 2009;131:8398-400.
15. Gao Q, Xu Y, Wu D, et al. Synthesis, characterization, and in vitro pH-controllable drug release from mesoporous silica spheres with switchable gates. Langmuir 2010;26:17133-8.
16. Mahkam M. Synthesis and characterization of novel positive-charge functionalized silica nanoparticles for oral drug delivery. J Biomater Nanobiotechnol 2012;3:391-5.
17. 4 nanoparticles-capped meso-porous silica. Biomater 2011;32:1932-42.
18. He Q, Gao Y, Zhang L, et al. A pH-responsive mesoporous silica nanoparticles-based multi-drug delivery system for overcoming multi-drug resistance. Biomaterials 2011;32:7711-20.
19. Singh N, Karambelkar A, Gu L, et al. Bioresponsive mesoporous silica nanoparticles for triggered drug release. JACS 2011;133: 19582-5.
20. Knezević NZ, Trewyn BG, Lin VSY. Light-and pH-responsive release of doxorubicin from a mesoporous silica-based nanocarrier. Chem Eur J 2011;17:3338-42.
21. Guo S, Qiao Y, Wang W, et al. A Poly(3-caprolactone)-graft-poly(2-(N, N-dimethylamino) ethyl methacrylate)nanoparticles: pH dependent thermo-sensitive multifunctional carriers for gene and drug delivery. J Mater Chem 2010;20:6935-41.
22. Chang B, Sha X, Guo J, et al. Thermo and pH dual responsive, polymer shell coated, magnetic mesoporous silica nanoparticles for controlled drug release. J Mater Chem 2011;21:9239-47.
23. Schmaljohann D. Thermo-and pH-responsive polymers in drug delivery. Adv Drug Delivery Rev 2006;58:1655-70.
24. Hu CH, Zhang XZ, Zhang L, et al. Temperature-and pH-sensitive hydrogels to immobilize heparin-modifiedPEI/DNA complexes for sustained gene delivery. J Mater Chem 2009;19:8982-9.
25. Soppimath KS, Tan DCW, Yang YY. pH-triggered thermally responsive polymer core-shell nanoparticles for drug delivery. Adv Mater 2005;17:318-23.
26. Zhang LY, Guo R, Yang M, et al. Thermo and pH dual-responsive nanoparticles for anti-cancer drug delivery. Adv Mater 2007;19: 2988-92.
27. Hong CY, Li X, Pan CY. Fabrication of smart nanocontainers with a mesoporous core and a pH-responsive shell for controlled uptake and release. J Mater Chem 2009;19:5155-60.
28. Aluri S, Janib SM, Mackay JA. Environmentally responsive peptides as anticancer drug carriers. Adv Drug Deliv Rev 2009; 61:940-52.
29. Yang Q, Wang SC, Fan PW, et al. pH-responsive carrier system based on carboxylic acid modified mesoporous silica and poly-electrolyte for drug delivery. Chem Mater 2005;17:5999-6003.
30. Zhou ZY, Zhu SM, Zhang D. Grafting of thermo-responsive polymer inside mesoporous silica with large pore size using ATRP and investigation of its use in drug release. J Mater Chem 2007;17: 2428-33.
31. Chruściel J, Slusarski L. Synthesis of nanosilica by the sol-gel method and its activity toward polymers. Mater Sci 2003;21: 461-9.
32. Jafarzadeh M, Rahman I, Sipaut C. Synthesis of silica nanoparticles by modified sol-gel process: the effect of mixing modes of the reactants and drying techniques. J Solgel Sci Technol 2009;50: 328-36.
33. Xu X, Yang L, Xu X, et al. Ultrafine medicated fibers electrospun from W/O emulsions. J Control Release 2005;108:33-42.
34. Salehi R, Irani M, Rashidi M-R, et al. Stimuli-responsive nanofibers prepared from poly (N-isopropylacrylamide-acryl-amide-vinylpyrrolidone) by electrospinning as an anticancer drug delivery. Des Monomers Polym 2013;16:515-27.
35. Vandghanooni S, Forouharmehr A, Eskandani M, et al. Cytotoxicity and DNA fragmentation properties of butylated hydroxyanisole. DNA Cell Biol 2013;32:98-103.
36. Liu C, Guo J, Yang W, et al. Magnetic mesoporous silica microspheres with thermo-sensitive polymer shell for controlled drug release. J Mater Chem 2009;19:4764-70.
37. Lin J, Chen H, Ji Y, Zhang Y. Functionally modified monodis-perse core-shell silica nanoparticles: silane coupling agent as capping and size tuning agent. Colloids Surf A Physicochem Eng Asp 2012;411:111-21.
38. Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 1986;46:6387-92.
39. Shi X, Wang Y, Varshney RR, et al. In-vitro osteogenesis of synovium stem cells induced by controlled release of bisphosphate additives from microspherical mesoporous silica composite. Biomater 2009;30:3996-4005.
40. Yuan L, Tang Q, Yang D, et al. Preparation of pH-responsive mesoporous silica nanoparticles and their application in controlled drug delivery. J Phys Chem C 2011;115:9926-32.
41. 4: Eu3+ functionalized mesoporous silica nanoparticles for magnetic resonance imaging and drug delivery. Dalton Trans 2013;42:6523-30.
42. Liu Q, Zhang J, Sun W, et al. Delivering hydrophilic and hydrophobic chemotherapeutics simultaneously by magnetic mesoporous silica nanoparticles to inhibit cancer cells. Int J Nanomedicine 2012;7:999-1013.
43. Kimelberg HK, Tracy TF, Biddlecome SM, Bourke RS. The effect of entrapment in liposomes on the in vivo distribution of [3H] methotrexate in a primate. Cancer Res 1976;36:2949-57.
44. Carino IS, Pasqua L, Testa F, et al. Silica-based mesoporous materials as drug delivery system for methotrexate release. Drug Deliv 2007;14:491-5.
45. Wen H, Guo J, Chang B, Yang W. pH-responsive composite microspheres based on magnetic mesoporous silica nanoparticle for drug delivery. Eur J Pharm Biopharm 2013;84:91-8.
46. Engin K, Leeper D, Cater J, et al. Extracellular pH distribution in human tumours. Int J Hyperthermia 1995;11:211-16.
47. Chertok B, Moffat BA, David AE, et al. Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors. Biomater 2008;29:487-96.
48. Karanth H, Murthy R. pH-sensitive liposomes-principle and application in cancer therapy. J Pharm Pharma 2007;59:469-83.
49. Liu Y, Cao X, Luo M, et al. Self-assembled micellar nanoparticles of a novel star copolymer for thermo and pH dual-responsive drug release. J Colloid Interface Sci 2009;329:244-52.
50. Wei L, Cai C, Lin J, Chen T. Dual-drug delivery system based on hydrogel/micelle composites. Biomater 2009;30:2606-13.
51. Shen JM, Gao FY, Yin T, et al. cRGD-functionalized polymeric magnetic nanoparticles as a dual-drug delivery system for safe targeted cancer therapy. Pharm Res 2013;70:102-15.
52. Xiong W, Wang W, Wang Y, et al. Dual temperature/pH-sensitive drug delivery of poly(N-isopropylacrylamide-co-acrylic acid) nanogels conjugated with doxorubicin for potential application in tumor hyperthermia therapy. Colloids Surf B Biointerfaces 2011; 84:447-53.